Bank of America’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.89M | Buy |
134,939
+38,134
| +39% | +$1.66M | ﹤0.01% | 3173 |
|
|
2025
Q1 | $2.65M | Buy |
96,805
+34,545
| +55% | +$945K | ﹤0.01% | 3713 |
|
|
2024
Q4 | $2.5M | Sell |
62,260
-48,772
| -44% | -$1.96M | ﹤0.01% | 3586 |
|
|
2024
Q3 | $5.26M | Sell |
111,032
-40,159
| -27% | -$1.9M | ﹤0.01% | 3156 |
|
|
2024
Q2 | $4.51M | Sell |
151,191
-11,100
| -7% | -$331K | ﹤0.01% | 3174 |
|
|
2024
Q1 | $6.52M | Buy |
162,291
+132,293
| +441% | +$5.32M | ﹤0.01% | 2873 |
|
|
2023
Q4 | $764K | Sell |
29,998
-58,667
| -66% | -$1.49M | ﹤0.01% | 4328 |
|
|
2023
Q3 | $1.23M | Sell |
88,665
-51,359
| -37% | -$714K | ﹤0.01% | 3892 |
|
|
2023
Q2 | $3.22M | Sell |
140,024
-136,764
| -49% | -$3.14M | ﹤0.01% | 3205 |
|
|
2023
Q1 | $8.2M | Buy |
276,788
+69,905
| +34% | +$2.07M | ﹤0.01% | 2583 |
|
|
2022
Q4 | $5.16M | Buy |
206,883
+81,307
| +65% | +$2.03M | ﹤0.01% | 2868 |
|
|
2022
Q3 | $2.73M | Buy |
125,576
+6,463
| +5% | +$141K | ﹤0.01% | 3403 |
|
|
2022
Q2 | $2.35M | Sell |
119,113
-10,125
| -8% | -$199K | ﹤0.01% | 3593 |
|
|
2022
Q1 | $5.47M | Buy |
129,238
+56,818
| +78% | +$2.4M | ﹤0.01% | 3050 |
|
|
2021
Q4 | $4.6M | Buy |
72,420
+36,414
| +101% | +$2.31M | ﹤0.01% | 3201 |
|
|
2021
Q3 | $2.12M | Buy |
36,006
+27,654
| +331% | +$1.62M | ﹤0.01% | 3747 |
|
|
2021
Q2 | $405K | Sell |
8,352
-24,003
| -74% | -$1.16M | ﹤0.01% | 4857 |
|
|
2021
Q1 | $1.26M | Buy |
32,355
+28,551
| +751% | +$1.11M | ﹤0.01% | 4085 |
|
|
2020
Q4 | $236K | Buy |
3,804
+1,357
| +55% | +$84.2K | ﹤0.01% | 4783 |
|
|
2020
Q3 | $79K | Buy |
+2,447
| New | +$79K | ﹤0.01% | 5166 |
|